on Redwood AI Corp. (CVE:AIRX)
Redwood AI to Showcase Technology at BIO-Europe Spring 2026
Redwood AI Corp. has been selected to present at BIO-Europe Spring 2026 in Lisbon, a significant event for biotech partnering. This selection followed a competitive process for the event's presentation program. The conference brings together biotech executives, pharmaceutical companies, investors, and industry experts to foster collaboration and explore new commercial opportunities.
CEO Louis Dron will present Redwood's AI-driven platform, Reactosphere, designed for chemical synthesis and research. The platform aims to automate synthesis evaluation, integrate practical constraints, and connect predictive chemistry with operational factors, potentially reducing risks and enhancing project execution.
The presentation will highlight the platform's applications in pharmaceuticals, public safety, and defense. The event, attracting over 3,700 attendees, reinforces its role as a major global biotech gathering.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Redwood AI Corp. news